XML 79 R46.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Earnings Per Share - Narrative (Details) - USD ($)
12 Months Ended
Aug. 13, 2018
Aug. 09, 2018
Mar. 21, 2018
Mar. 19, 2018
Mar. 23, 2016
Dec. 28, 2019
Dec. 29, 2018
Dec. 30, 2017
Mar. 26, 2013
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                  
Proceeds from exercise of unit warrant           $ 0 $ 1,093,000 $ 0  
Exercise price per warrant unit (in usd per share)                 $ 7.80
Proceeds from issuance of common stock           $ 0 $ 100,330,000 $ 0  
Follow-on offering | Firm shares                  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                  
Proceeds from secondary offering, net of costs (in shares)   1,270,000              
Shares issued, price per share   $ 79.00              
Underwriter | Follow-on offering | Firm shares                  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                  
Proceeds from issuance of common stock $ 93,469                
Underwriter | Follow-on offering | Share-based payment arrangement, option                  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                  
Proceeds from secondary offering, net of costs (in shares)   190,500              
Unit warrant | Underwriter                  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                  
Warrant units (in shares)                 140,000
Proceeds from exercise of unit warrant       $ 1,093 $ 1,008        
Proceeds from exercise of warrants, net of costs (in shares)     140,000            
Restricted Stock                  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                  
Non-vested restricted shares           642,677 614,911 570,171